High-risk drug use among Palestinian adolescent refugees in the North West Bank Palestine.

Drug abuse Palestine Palestinian refugee adolescents THC UNRWA amphetamine depression

Journal

Journal of ethnicity in substance abuse
ISSN: 1533-2659
Titre abrégé: J Ethn Subst Abuse
Pays: England
ID NLM: 101083217

Informations de publication

Date de publication:
12 Sep 2023
Historique:
medline: 12 9 2023
pubmed: 12 9 2023
entrez: 12 9 2023
Statut: aheadofprint

Résumé

Palestinian adolescent refugees are at increased risk for behaviors that can lead to poor health outcomes, such as high-risk substance use. This research focuses on the prevalence of substance use and its relationship with depression among adolescent male refugees in Palestine's North-West Bank. A cross-sectional study was conducted in five of seven refugee camps to gather data using a proportional stratified sampling technique. A structured questionnaire-based interview was conducted to gather sociodemographic data, self-reported substance use, and depression scale information. Additionally, urine screening tests were used to detect the presence of different drugs in participants' urine samples. The final sample size was 386 refugee males; 24.0% were workers, and 13.7% worked previously. For self-reported substance use, 26.9%;12.4%; 28.0%; 37.0%; and 60.4%, 2.6% of adolescents reported current users of cigarettes, e-cigarettes, waterpipe, coffee, energy drinks (ED), and alcohol, respectively. Moreover, 3.4% tested positive for at least one drug. The drugs that tested positive were as follows: PCP (5%), MDMA (1.8%), THC (1.6%), BZO (0.5%), and MET (0.5%). The adjusted logistic regression showed an increased risk of depression among workers (OR = 3.777;

Identifiants

pubmed: 37698173
doi: 10.1080/15332640.2023.2255850
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-20

Auteurs

Motaz Snoubar (M)

An-Najah National University, Nablus, Palestine.

Salih Kasim (S)

An-Najah National University, Nablus, Palestine.

Mahdi Badawi (M)

An-Najah National University, Nablus, Palestine.

Qusay Shaban (Q)

An-Najah National University, Nablus, Palestine.

Ibraheem AbuAlrub (I)

An-Najah National University, Nablus, Palestine.

Marah Hunjul (M)

An-Najah National University, Nablus, Palestine.

Nashat Khelfeh (N)

An-Najah National University, Nablus, Palestine.

Ahmad Abuhassan (A)

An-Najah National University, Nablus, Palestine.

Ahmad Hanani (A)

An-Najah National University, Nablus, Palestine.

Saed Bilbeisi (S)

Opioid Substitution Therapy Unit, Ramallah, Palestine.

Basma Damiri (B)

An-Najah National University, Nablus, Palestine.

Classifications MeSH